Skip to main content

Abstract

This 77-year-old female with breast cancer diagnosed 28 years ago developed recurrence after 21 years. Even with chemotherapy and radiotherapy the disease metastasized to the lungs and left adrenal gland.

Keywords

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Shields CL, Shields JA, Gross NE, et al. Survey of 520 eyes with uveal metastases. Ophthalmology. 1997;104:1265–76.

    Article  CAS  PubMed  Google Scholar 

  2. Demirci H, Shields CL, Chao A, Shields JA. Uveal metastasis from breast cancer in 264 patients. Am J Ophthalmol. 2003;136:264–71.

    Article  PubMed  Google Scholar 

  3. Chang EL, Lo S. Diagnosis and management of central nervous system metastases from breast cancer. Oncologist. 2003;8:398–410.

    Article  PubMed  Google Scholar 

  4. Hui KH, Pfeiffer ML, Esmaeli B. Value of PET/CT in diagnosis and staging of primary ocular and orbital tumors. Saudi J Ophthalmol. 2012;26:365–71.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Shulman JP, Latkany P, Chin KJ, Finger PT. Whole-body 18FDG PET-CT imaging of systemic sarcoidosis: ophthalmic oncology and uveitis. Ocul Immunol Inflamm. 2009;17(2):95–100.

    Article  CAS  PubMed  Google Scholar 

  6. Nguyen BD, Roarke MC. Choroidal and extraocular muscle metastases from non-small-cell lung carcinoma: F18 FDG PET/CT imaging. Clin Nucl Med. 2008;33(2):118–21.

    Article  PubMed  Google Scholar 

  7. Solav S, Bhandari R, Sowani A, Saxena S. Choroidal metastasis from carcinoma of breast detected on F18-FDG PET CT scan: a case report and review of literature. Indian J Nucl Med. 2010;25(4):160–3.

    PubMed Central  PubMed  Google Scholar 

  8. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Available at: http://www.cbtrus.org. Accessed 3 Nov 2013.

  9. Taha M, Ahmad A, Wharton S, Jellinek D. Extra-cranial metastasis of glioblastoma multiforme presenting as acute parotitis. Br J Neurosurg. 2005;19:348–51.

    Article  CAS  PubMed  Google Scholar 

  10. Robert MC, Wastie ML. Glioblastoma multiforme: a rare manifestation of extensive liver and bone metastases. Biomed Imaging Interv J. 2008;4(1):e3.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Padoma MV, Said S, Jacobs M, et al. Prediction of pathology and survival by FDG PET in gliomas. J Neurooncol. 2003;64:227–37.

    Article  Google Scholar 

  12. Langleben DD, Segall GM. PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med. 2000;41:1861–7.

    CAS  PubMed  Google Scholar 

  13. Chen W. Clinical applications of PET in brain tumors. J Nucl Med. 2007;48:1468–81.

    Article  PubMed  Google Scholar 

  14. Intriago B, Danús M, Añaños M, et al. 18F-FDG PET detection of spinal leptomeningeal metastases from cerebral glioblastoma multiforme. Eur J Nucl Med Mol Imaging. 2011;38:1392.

    Article  PubMed  Google Scholar 

  15. Astner ST, Pihusch R, Nieder C, et al. Extensive local and systemic therapy in extraneural metastasized glioblastoma multiforme. Anticancer Res. 2006;26:4917–20.

    PubMed  Google Scholar 

  16. Song HJ, Xue YL, Xu YH. Rare metastases of differentiated thyroid carcinoma: pictorial review. Endocr Relat Cancer. 2011;18:R165–74.

    Article  CAS  PubMed  Google Scholar 

  17. Kumar A, Nadig M, Patra V, Srivastava DN, et al. Adrenal and renal metastases from follicular thyroid cancer. Br J Radiol. 2005;78:1038–41.

    Article  CAS  PubMed  Google Scholar 

  18. Davidson T, Goitein O, Avigdor A, et al. 18F-FDG-PET/CT for the diagnosis of tumor thrombosis. Isr Med Assoc J. 2009;11:69–73.

    PubMed  Google Scholar 

  19. Mugunthan N, Kumar AR, Thomas P. Tumor thrombus in the great veins from papillary carcinoma of the thyroid: I 131 findings. J Clin Endocrinol Metab. 2010;95:2527–8.

    Article  CAS  PubMed  Google Scholar 

  20. Sugimoto S, Doihara H, Ogasawara Y. Intraatrial extension of thyroid cancer: a case report. Acta Med Okayama. 2006;60:135–40.

    PubMed  Google Scholar 

  21. Engelbrecht M, Akin O, Dixit D, Schwartz L. Bland and tumor thrombi in abdominal malignancies: magnetic resonance imagingassessment in a large oncologic patient population. Abdom Imaging. 2011;36(1):62–8.

    Article  PubMed  Google Scholar 

  22. Knipe H, Jha P, et al. Inferior vena caval thrombosis (n.d.). Radiopaedia.org. Retrieved from http://radiopaedia.org/articles/inferior-vena-caval-thrombosis.

  23. Lai P, Bomanji JB, Mahmood S, et al. Detection of tumour thrombus by 18F-FDG-PET/CT imaging. Eur J Cancer Prev. 2007;16(1):90–4.

    Article  CAS  PubMed  Google Scholar 

  24. Sharma P, Kumar R, Singh H, et al. Imaging thrombus in cancer patients with FDG PET–CT. Jpn J Radiol. 2012;30(2):95–104.

    Article  PubMed  Google Scholar 

  25. Rondina MT, Lam UT, Pendleton RC, et al. (18)F-FDG PET in the evaluation of acuity of deep vein thrombosis. Clin Nucl Med. 2012;37(12):1139–45.

    PubMed Central  PubMed  Google Scholar 

  26. Walkey MM, Friedman AC, Sohotra P, Radecki PD. CT manifestations of peritoneal carcinomatosis. AJR Am J Roentgenol. 1988;150:1035–41.

    Article  CAS  PubMed  Google Scholar 

  27. Dirisamer A, Schima W, Heinisch M, et al. Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET/MDCT. Eur J Radiol. 2009;69:536–41.

    Article  PubMed  Google Scholar 

  28. Turlakow A, Yeung HW, Salmon AS, et al. Peritoneal carcinomatosis: role of 18F-FDG PET. J Nucl Med. 2003;44:1407–12.

    PubMed  Google Scholar 

  29. Gaetano AM, Calcagni ML, Rufini V, et al. Imaging of peritoneal carcinomatosis with FDG PET-CT: diagnostic patterns, case examples and pitfalls. Abdom Imaging. 2009;34:391–402.

    Article  PubMed  Google Scholar 

  30. Metser U, Goor O, Lerman H, et al. PET–CT of extranodal lymphoma. AJR Am J Roentgenol. 2004;182(6):1579–86.

    Article  PubMed  Google Scholar 

  31. Blodgett TM, Ames JT, Torok FS, et al. Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin. Clin Nucl Med. 2004;29(3):161–3.

    Article  PubMed  Google Scholar 

  32. Berthet L, Cochet A, Karoun S, et al. In newly diagnosed DLBCL, determination of bone marrow involvement with FDG PET CT provides better diagnostic performance and prognostic stratification than does bone marrow biopsy. J Nucl Med. 2013;54(6):1244–50.

    Article  CAS  PubMed  Google Scholar 

  33. Molina CA, Gokaslan ZL, Sciubba DM. Diagnosis and management of metastatic cervical spine tumors. Orthop Clin North Am. 2012;43:75–87.

    Article  PubMed  Google Scholar 

  34. Gasbarrini A, Cappuccio M, Mirabile L, et al. Spinal metastases: treatment evaluation algorithm. Eur Rev Med Pharmacol Sci. 2004;8:265–74.

    CAS  PubMed  Google Scholar 

  35. Song JW, Oh YM, Shim TS, et al. Efficacy comparison between 18F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer. Lung Cancer. 2009;65(3):333–8.

    Article  PubMed  Google Scholar 

  36. Kim DW, Kim SC, Krynyckyi BR, et al. Focally increased activity in the lateral aspect of the mid cervical spine on bone scintigraphy is almost always benign in nature. Clin Nucl Med. 2005;30:593–5.

    Article  PubMed  Google Scholar 

  37. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29:252–60.

    Article  CAS  PubMed  Google Scholar 

  38. Ferry JA. Extranodal lymphomas. Philadelphia: Elsevier/Saunders; 2011.

    Google Scholar 

  39. Freudenberg LS, Antoch G, Schutt P, et al. FDG-PET/CT in restaging of patients with lymphoma. Eur J Nucl Med Mol Imaging. 2004;31:325–9.

    Article  CAS  PubMed  Google Scholar 

  40. Yeung HW, Grewal RK, Gonen M, et al. Patterns of FDG uptake in adipose tissue and muscle: a potential source of false positives for PET. J Nucl Med. 2003;44:1789–96.

    PubMed  Google Scholar 

  41. Schoder H, Meta J, Yap C, et al. Effect of whole body FDG-PET imaging on clinical staging and management of patients with malignant lymphoma. J Nucl Med. 2001;42:1139–43.

    CAS  PubMed  Google Scholar 

  42. Meier F, Will S, Ellwanger U, et al. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol. 2002;147:62–70.

    Article  CAS  PubMed  Google Scholar 

  43. Blecker D, Abraham S, Furth EE, et al. Melanoma in the GI tract. Am J Gastroenterol. 1999;94:3427–33.

    Article  CAS  PubMed  Google Scholar 

  44. Chao XS, Li Q, Chen H. Small bowel metastases of malignant melanoma: palliative effect of surgical resection. Jpn J Clin Oncol. 1999;29:442–4.

    Article  Google Scholar 

  45. Kadakia SC, Parker A, Canales L. Metastatic tumors to the upper gastrointestinal tract: endoscopic experience. Am J Gastroenterol. 1992;87:1418–23.

    CAS  PubMed  Google Scholar 

  46. Schoder H, Larson SM, Yeung HWD. PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies. J Nucl Med. 2004;45:72S–81.

    PubMed  Google Scholar 

  47. Belhocine T, Pierard G, de Labrassinne M, et al. Staging of regional nodes in AJCC stage I and II melanoma: FDG PET imaging versus sentinel node detection. Oncologist. 2002;7:271–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Santiago, J.F.Y. (2015). Unusual Metastatic Sites. In: Positron Emission Tomography with Computed Tomography (PET/CT). Springer, Cham. https://doi.org/10.1007/978-3-319-05518-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-05518-3_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-05517-6

  • Online ISBN: 978-3-319-05518-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics